PRW Wealth Management’s Pfizer PFE Stock Holding History

PRW Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,264	Closed	-$205K	–	103
2023 Q1	$205K	Hold	5,264	–	–	0.08%	108
2022 Q4	$270K	Hold	5,264	–	–	0.12%	49
2022 Q3	$230K	Hold	5,264	–	–	0.11%	81
2022 Q2	$276K	Hold	5,264	–	–	0.16%	69
2022 Q1	$273K	Buy	5,264 +885	+20%	+$45.9K	0.12%	85
2021 Q4	$258K	Buy	+4,379	New	+$217K	0.12%	80
2021 Q3	–	Sell	-10,907	Closed	-$427K	–	235
2021 Q2	$427K	Buy	+10,907	New	+$424K	0.13%	172
2019 Q2	–	Sell	-2,163	Closed	-$88K	–	496
2019 Q1	$88K	Sell	2,163 -54	-2%	-$2.16K	0.08%	89
2018 Q4	$92K	Buy	+2,217	New	+$92K	0.11%	96

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PRW Wealth Management's PFE Position: Q2 2023 in Review

PRW Wealth Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,264 shares — an estimated $205K sold.

PRW Wealth Management first reported a position in PFE in Q4 2018 and held it in 9 quarters. The position peaked at $427K in Q2 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

PRW Wealth Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
PRW Wealth Management sold 5,264 Pfizer shares in Q2 2023, an estimated $205K.
PRW Wealth Management first reported a position in Pfizer in Q4 2018 and held it in 9 quarters.
PRW Wealth Management's Pfizer position peaked at $427K in Q2 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on PRW Wealth Management's 13F filing for Q2 2023, filed 1 Aug 2023.